Taner Bayraktaroğlu

1.0k total citations
71 papers, 659 citations indexed

About

Taner Bayraktaroğlu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Taner Bayraktaroğlu has authored 71 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Taner Bayraktaroğlu's work include Thyroid Cancer Diagnosis and Treatment (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Taner Bayraktaroğlu is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Taner Bayraktaroğlu collaborates with scholars based in Türkiye, Australia and Netherlands. Taner Bayraktaroğlu's co-authors include Mehmet Kanter, Ömer Çoşkun, Ayşe Ferda Ocakçı, Selim Aydemir, Yücel Üstündağ, Görkem Mungan, Murat Can, Ali Borazan, Şerefden Açıkgöz and Berrak Güven and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Clinical Endocrinology.

In The Last Decade

Taner Bayraktaroğlu

60 papers receiving 633 citations

Peers

Countries citing papers authored by Taner Bayraktaroğlu

Since Specialization

Citations

This map shows the geographic impact of Taner Bayraktaroğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taner Bayraktaroğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taner Bayraktaroğlu more than expected).

Fields of papers citing papers by Taner Bayraktaroğlu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taner Bayraktaroğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taner Bayraktaroğlu. The network helps show where Taner Bayraktaroğlu may publish in the future.

Co-authorship network of co-authors of Taner Bayraktaroğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Taner Bayraktaroğlu. A scholar is included among the top collaborators of Taner Bayraktaroğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taner Bayraktaroğlu. Taner Bayraktaroğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study 2023 ·Endocrine ·(unknown), (unknown), (unknown), (unknown), Mazhar Müslüm Tuna, (unknown), Gülhan Akbaba, Faruk Kılınç, (unknown), (unknown), (unknown), (unknown), Pınar Kadıoğlu, Neşe Çınar, Taner Bayraktaroğlu, Birol Topçu, Yüksel Altuntaş, Gülşah Elbüken	4
2	Injection site reaction induced by liraglutide use in a female patient with obesity 2023 ·JCEM Case Reports ·(unknown), (unknown), (unknown), Taner Bayraktaroğlu	1
3	Difficulty in Follow-Up of Papillary Thyroid Cancer Co-Existent with Hypopituitarism: Case Report and Review of the Literature 2022 ·DergiPark (Istanbul University) ·(unknown), (unknown), (unknown), (unknown), (unknown), Güldeniz Karadeniz Çakmak, Taner Bayraktaroğlu	0
4	Differences in Clinical Aspects Between Subacute Thyroiditis Associated with COVID-19 Vaccines and Classical Subacute Thyroiditis 2022 ·Hormone and Metabolic Research ·(unknown), (unknown), (unknown), Taner Bayraktaroğlu	6
5	Epidemiyolojide Gözlemsel Çalışmaların Raporlanması: STROBE Kriterlerinin Türkçe Uyarlaması 2021 ·Zonguldak Bülent Ecevit University Institutional Repository ·(unknown), (unknown), Çağatay Büyükuysal, Mustafa Tözün, Ferhan Elmalı, Taner Bayraktaroğlu, Mustafa Agâh Tekindal	8
6	Zonguldak Bülent Ecevit Üniversitesi Tıp Fakültesi 2020-2021 Eğitim Yılı Dönem 3 Öğrencileri Kanıta Dayalı Tıp Çalışmaları Özetleri 2021 ·(unknown), Ferruh Niyazi Ayoğlu, Hande Aydemir, Murat Can, Taner Bayraktaroğlu	0
7	Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study 2021 ·Endocrine Practice ·(unknown), (unknown), Mehmet Çelik, (unknown), (unknown), Faruk Kılınç, Gülhan Akbaba, Neşe Çınar, (unknown), Serdar Şahin, (unknown), Gülşah Elbüken, Sibel Güldiken, Pınar Kadıoğlu, Taner Bayraktaroğlu, Birol Topçu, Yüksel Altuntaş	7
8	COVID-19 ve Hipertansiyon 2020 ·Zonguldak Bülent Ecevit University Institutional Repository ·(unknown), Taner Bayraktaroğlu	2
9	Tip 2 Diabetes Mellitus’lu Olgularda Glisemik Kontrol Düzeyinin Fonksiyonel Mobilite ve Ayak Fonksiyonuna Etkisi 2019 ·Zonguldak Bülent Ecevit University Institutional Repository ·(unknown), (unknown), (unknown), Taner Bayraktaroğlu	1
10	Increased Serum Levels of IL-28 and IL-29 and the Protective Effect ofIL28Brs8099917 Polymorphism in Patients with Hashimoto’s Thyroiditis 2016 ·Immunological Investigations ·Dilek Arpacı, Sevim Çelik, Murat Can, (unknown), (unknown), Mustafa Ünal, Taner Bayraktaroğlu	19
11	A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review 2015 ·Nigerian Journal of Clinical Practice ·(unknown), Taner Bayraktaroğlu, (unknown), (unknown), (unknown), Murat Kalaycı	5
12	Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer 2015 ·Oncology Letters ·Cemil Bilir, Hüseyin Engin, Murat Can, (unknown), (unknown), (unknown), Taner Bayraktaroğlu	15
13	Severe hypertriglyceridemia and triglyceride apheresis 2009 ·Endocrine Abstracts ·Taner Bayraktaroğlu, Mesut Özkaya, Faruk Kutlutürk, (unknown), (unknown)	2
14	Geç Ortaya Çıkan Tip 1 Otoimmün Poliglandüler Yetersizlik Sendromlu Bir Olgu 2007 ·Turkiye Klinikleri Tip Bilimleri Dergisi ·Taner Bayraktaroğlu, Harika Boztepe, Sema Yarman, Refik Tanakol, Faruk Alagöl	1
15	A case with hypercalcemia caused by hyperparathyroidism and multiple myeloma 2007 ·(unknown), Taner Bayraktaroğlu, Ayşe Kubat Üzüm, Sevgi Kalayoğlu Beşışık, Ferihan Aral, (unknown), (unknown), Faruk Alagöl	1
16	Interleukin-6-producing pheochromocytoma presenting with fever of unknown origin 2007 ·(unknown), Sema Yarman, (unknown), Taner Bayraktaroğlu, Meral Mert, Refik Tanakol	1
17	Hipopituitarizm ve Replasman Tedavisi 2007 ·Turkiye Klinikleri Tip Bilimleri Dergisi ·Taner Bayraktaroğlu, (unknown)	0
18	Clodronic Acid in the Treatment of Postmenopausal Osteoporosis 2007 ·Clinical Drug Investigation ·Refik Tanakol, Sema Yarman, Taner Bayraktaroğlu, Harika Boztepe, (unknown)	8
19	Serum Cardiovascular Risk Factors in Obstructive Sleep Apnea 2006 ·CHEST Journal ·Murat Can, Şerefden Açıkgöz, Görkem Mungan, Taner Bayraktaroğlu, Erdem Koçak, Berrak Güven, Selda Demırtaş	109
20	Standart üçlü tedavi ile eradikasyon sağlanamayan Helicobacter pylori enfeksiyonunda lansoprazol, ranitidin bizmut sitrat, tetrasiklin ve metronidazolden oluşan dörtlü tedavinin etkinliği 2004 ·Selim Aydemir, Taner Bayraktaroğlu, Yücel Üstündağ, Ali Borazan, (unknown), Erol Aktunç, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact